KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea
· Delayed Price · Currency is KRW 2,585.00
-170.00 (-6.17%)
At close: Apr 13, 2026
KMPHARMACEUTICAL Revenue
In the year 2025, KMPHARMACEUTICAL had annual revenue of 15.99B KRW with 10.47% growth. KMPHARMACEUTICAL had revenue of 4.29B in the quarter ending December 31, 2025, with 26.41% growth.
Revenue
15.99B
Revenue Growth
+10.47%
P/S Ratio
0.90
Revenue / Employee
275.69M
Employees
58
Market Cap
14.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.99B | 1.52B | 10.47% |
| Dec 31, 2024 | 14.47B | -3.29B | -18.54% |
| Dec 31, 2023 | 17.77B | 2.14B | 13.68% |
| Dec 31, 2022 | 15.63B | -7.07B | -31.15% |
| Dec 31, 2021 | 22.71B | -223.00M | -0.97% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INNOGENE | 8.21B |
| Medience | 48.77B |
| Nord Mason | 21.26B |
| Ha U Dong Chun | 1.89B |
| Csa Cosmic | 27.93B |
| Outin Futures | 42.39B |
| Bonne | 46.01B |
| SR biotek | 1.62B |